Evidence map›Paper›PMID 21980542›Full record

ArticlePLoS neglected tropical diseases2011

Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent?

Meghan R Perry, Susan Wyllie, Vijay Kumar Prajapati, Joerg Feldmann, Shyam Sundar, Marleen Boelaert, Alan H Fairlamb

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. MRPA-independent mechanisms of antimony resistance in Leishmania infantum.International journal for parasitology. Drugs and drug resistance · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. VOSalophen: a vanadium complex with a stilbene derivative-induction of apoptosis, autophagy, and efficiency in experimental cutaneous leishmaniasis.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2017
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Chronic arsenic exposure and microbial drug resistance.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  19. Article
  20. Antimony resistance and environment: Elusive links to explore during Leishmania life cycle.International journal for parasitology. Drugs and drug resistance · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Meghan R PerryDivision of Biological Chemistry and Drug Discovery, College of Life Sciences, University of Dundee, Dundee, Scotland, UK.
Susan Wyllie
Vijay Kumar Prajapati
Joerg Feldmann
Shyam Sundar
Marleen Boelaert
Alan H Fairlamb

Funding

Wellcome TrustWellcome Trust 079838Wellcome Trust 090665
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug ResistanceAntimonyAntiprotozoal AgentsArsenicHumansIndiaLeishmaniaLeishmania donovaniLeishmania infantumLeishmaniasis, VisceralPoisonsTreatment FailureAntimonyAntiprotozoal AgentsArsenicPoisons

Identifiers

PMID21980542
PMCPMC3181240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.